To measure the frequency of persistent liver dysfunction (raised liver enzymes, serumalbumin, prothrombin time, etc) in recovered COVID -19 patients.To compare the hepatic manifestations in post COVID -19 patients with and without liverdisease
The digestive tract, particularly the liver, has recently been reported to be affected by
SARS-CoV-2. Although abnormal liver enzymes were regularly described as an
extra-pulmonary clinical feature, and almost one half of patients experienced grades of
hepatic injury. liver damage in patients with SARS infections was primarily manifested in
the mild and moderate elevation of alanine and/or aspartate aminotransferases (ALT and
AST) with some degree of hypoalbuminemia and hyperbilirubinemia during the early stage of
the illness.
Diagnostic Test: liver function , prothrombin time , INR , US .
analytic
Inclusion Criteria:
- Patients previously diagnosed by COVID 19 eg : PCR and / or HRCT chest, lab of more
than 1 month duration.
Exclusion Criteria:
- Patients less than 18 y.
- Patients with acute COVID 19.
Faculty of Medicine
Assiut, Egypt
Khaled Abu Bakr, Study Director
Assiut University